B oth men and women with psoriasis are equally at risk for developing psoriatic arthritis (PsA)-a chronic inflammatory ...

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

IL-17 inhibitors are approved for axial spondyloarthritis and psoriatic arthritis, but their effectiveness in heavily ...

Many people with psoriatic arthritis will experience symptoms in their feet. This can lead to swollen toes, pitted nails, ...

Psoriatic arthritis (PsA) is inflammatory arthritis that affects individuals with psoriasis. Psoriasis is a disease that causes red patches of skin with silvery scales. foot problems According to the ...

Plantar fasciitis, bunions, and arthritis are all among the common causes of foot pain. Learn what to do when your feet hurt and when to see a doctor.

Deucravacitinib met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic arthritis in the POETYK PsA-1 study, according to data presented at EULAR 2024 ...

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes. This study sought to explore the syndrome's role in a more precisely ...

Orthopedic surgeon shares the facts on ankle and foot arthritis and how they’re treated.

When India Bolton was diagnosed with psoriasis in college, she didn't expect a progression to psoriatic arthritis to happen so soon.

Tremfya reduced signs and symptoms of psoriatic arthritis, as well as progression of structural damage, according to new phase 3 results.